Abu Rous Fawzi, Gutta Radhika, Chacko Rebecca, Kuriakose Philip, Dabak Vrushali
Hematology and Oncology, Henry Ford Health System, Detroit, USA.
Internal Medicine, Henry Ford Health System, Detroit, USA.
Cureus. 2022 Jul 11;14(7):e26742. doi: 10.7759/cureus.26742. eCollection 2022 Jul.
Large granular lymphocytic (LGL) leukemia is a rare chronic lymphoproliferative disorder that can arise from T- or natural killer-cell lineages. It is an indolent disease that typically occurs in the sixth decade of life. Most cases of T-cell LGL leukemia (T-LGL) are associated with autoimmune disorders. Patients with T-LGL are generally asymptomatic; however, they can present with symptoms related to neutropenia, infections, and autoimmune disorders. Here, we report two cases of T-LGL in which the patients presented with liver dysfunction.
大颗粒淋巴细胞(LGL)白血病是一种罕见的慢性淋巴细胞增殖性疾病,可起源于T细胞或自然杀伤细胞谱系。它是一种惰性疾病,通常发生在人生的第六个十年。大多数T细胞LGL白血病(T-LGL)病例与自身免疫性疾病有关。T-LGL患者通常无症状;然而,他们可能会出现与中性粒细胞减少、感染和自身免疫性疾病相关的症状。在此,我们报告两例T-LGL患者出现肝功能障碍的病例。